{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:12Z","timestamp":1792521432244,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T14:22:46Z","timestamp":1468678966000},"page":"4278-4284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy"],"prefix":"10.1016","volume":"34","author":[{"given":"Paolo","family":"Durando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppina","family":"Desole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Salvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouzama","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Povey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.009_b0005","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2016.07.009_b0010","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"10.1016\/j.vaccine.2016.07.009_b0015","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.20.20480-en","article-title":"Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal","volume":"18","author":"Filia","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.07.009_b0020","first-page":"146","article-title":"Vaccine coverage in Italy and assessment of the 2012\u20132014 National Immunization Prevention Plan","volume":"39","author":"Bonanni","year":"2015","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.vaccine.2016.07.009_b0025","unstructured":"Ministero della Salute. Coperture vaccinali (%), calcolate sui riepiloghi inviati dalle Regioni e PP.AA. (per singolo antigene). Available from: http:\/\/www.salute.gov.it\/imgs\/C_17_tavole_20_allegati_iitemAllegati_17_fileAllegati_itemFile_0_file.pdf [last accessed: 9 May 2017]."},{"key":"10.1016\/j.vaccine.2016.07.009_b0030","series-title":"48\u00b0Congresso Nazionale Siti; 14\u201317 Ottobre 2015","article-title":"Andamento delle coperture vaccinali per varicella ed MPR in alcune regioni Italiane (2009\u20132014) [Abstract C9.2]","author":"Bechini","year":"2015"},{"key":"10.1016\/j.vaccine.2016.07.009_b0035","unstructured":"Ministero della Salute. Piano Nazionale Prevenzione Vaccinale (PNPV) 2012\u20132014. Available from: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_1721_allegato.pdf [last accessed: 17 May 2016]."},{"key":"10.1016\/j.vaccine.2016.07.009_b0040","first-page":"131","volume":"38","author":"Bonanni","year":"2014","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.vaccine.2016.07.009_b0045","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.vaccine.2011.03.043","article-title":"Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: an open, randomized controlled trial","volume":"29","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0050","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/hv.18650","volume":"8","author":"Ferrera","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.07.009_b0060","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12\u201316 months","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.009_b0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.07.009_b0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","article-title":"Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines","volume":"25","author":"Shinefield","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.009_b0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.009_b0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life","volume":"27","author":"Schuster","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.009_b0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.009_b0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","article-title":"Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination","volume":"32","author":"Schink","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0095","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.07.009_b0105","series-title":"XVIII Relazione sull\u2018attivita\u2019 del \u201ccanale verde\u201d","author":"Opri","year":"2014"},{"key":"10.1016\/j.vaccine.2016.07.009_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/21645515.2015.1101198","article-title":"A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy","volume":"12","author":"Cocchio","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.07.009_b0115","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0120","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(00)00016-5","article-title":"Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic","volume":"18","author":"Ozaki","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.009_b0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.88.3.604","article-title":"Immunogenicity of subcutaneous versus intramuscular Oka\/Merck varicella vaccination in healthy children","volume":"88","author":"Dennehy","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.07.009_b0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/hv.8269","article-title":"Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: a randomized, double-blind, cross-over study","volume":"5","author":"Ferrera","year":"2009","journal-title":"Hum Vaccin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:07:50Z","timestamp":1656810470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16305825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16305825"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 GlaxoSmithKline SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}